Latest Nitto Denko Stories

Leading Biotechnology Manufacturer NITTO DENKO Avecia Inc. broadens its offerings with its new OliGrow service Milford, Massachusetts (PRWEB) May 13, 2013 NITTO DENKO Avecia Inc., an industry leader in therapeutic nucleic acid manufacturing and development services, is proud to introduce a new pre-clinical oligonucleotide synthesis service, OliGrow. Combining phase appropriate quality and purity standards with a high level of customer service, the Avecia OliGrow team delivers pre-clinical...

Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) announced today that the U.S. Food and Drug Administration has granted approval for the Company's Abbreviated New Drug Application (ANDA) for Fentanyl Transdermal System, 25 mcg/hour, 50 mcg/hour, 75 mcg/hour and 100 mcg/hour, the AB-rated generic equivalent of Ortho McNeil's chronic pain treatment Duragesic(R). Shipment of this product has commenced. Total annual sales of this product for the strengths noted above, including both brand...